Shogo Yamaguchi Selected Research

Shogo Yamaguchi Research Topics

6	Heart Failure 03/2021 - 08/2018
3	Cardiogenic Shock 12/2020 - 01/2020
3	Myocarditis (Carditis) 01/2020 - 01/2018
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2021 - 07/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2020 - 01/2020
1	Chronic Renal Insufficiency 03/2024
1	Neoplasms (Cancer) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 02/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Pulmonary Edema 01/2021
1	Pulmonary Embolism 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Thrombosis (Thrombus) 10/2020
1	Cardiomyopathies (Cardiomyopathy) 02/2020
1	Polyuria 01/2020
1	Ventricular Tachycardia 01/2020
1	ST Elevation Myocardial Infarction 06/2019
1	Cardiac Tamponade 01/2019
1	Pericardial Effusion 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2019

2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
2	Oxygen (Dioxygen)IBA 03/2021 - 01/2021
1	Lipocalin-2IBA 03/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	AntibodiesIBA 01/2022
1	lenvatinibIBA 01/2022
1	FollistatinIBA 12/2021
1	Angiotensin Receptor AntagonistsIBA 07/2020
1	Amino Acids FDA Link 07/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2020
1	Hemoglobins (Hemoglobin)IBA 07/2020
1	Branched-Chain Amino AcidsIBA 07/2020
1	AnthracyclinesIBA 02/2020
1	Dobutamine FDA LinkGeneric 01/2020
1	Vasopressins (Vasopressin)IBA 01/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020
1	Lipoprotein(a)IBA 06/2019
1	Vasodilator Agents (Vasodilators)IBA 01/2019
1	NivolumabIBA 01/2018

5	Extracorporeal Membrane Oxygenation 01/2021 - 08/2018
4	Heart-Assist Devices 02/2021 - 02/2020
2	Therapeutics 01/2022 - 01/2018
1	Percutaneous Coronary Intervention 03/2024
1	Thrombectomy 10/2020
1	Intra-Aortic Balloon Pumping 01/2020